ORYZON presents safety and efficacy data of vafidemstat from the Phase II ESCAPE trial in severe CoVID-19 patients at ECCMID-2021

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, presented today...

Read more

A new method to find modulators of the immune response to COVID-19

by CIC bioGUNE

The recent paper, published in Science Advances by the Computational Biology Laboratory at CICbioGUNE, member of the Basque Research & Technology Alliance BRTA and at Luxembourg Centre for Systems Bio...

Read more

Two anti-inflammatory drugs found that inhibit the replication of the COVID-19 virus

by Universitat Rovira i Virgili

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcriptio...

Read more

A mechanism that limits interferon in immune responses discovered

by UPF - Universitat Pompeu Fabra

The study, led by Cristina López-Rodríguez and Jose Aramburu shows that the transcription factor NFAT5, which induces multiple inflammatory mediators, represses type I interferons.

Read more

An inflammatory diet correlates with colorectal cancer risk

by Hospital Universitari de Bellvitge

The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Theriva™ Biologics to Present Preclini...

by Theriva™ Biologics

Theriva™ Biologics has announced the presentation of preclinical da...

Photos Stream